Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability - PubMed (original) (raw)

Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability

P H Rabbitts et al. EMBO J. 1985.

Abstract

The human c-myc gene consists of three exons transcribed from two distinct promoters and the function of the first, noncoding exon is unknown. In COLO 320 cells, there co-exist normal and truncated (i.e., lacking exon 1) c-myc genes, both of which are transcribed. Studies on the turnover of c-myc mRNA show that the normal mRNA has an in vivo half-life of approximately 30 min which is approximately similar to the turnover time of the mRNA in lymphoblastoid cells. However, the truncated mRNA was found to be substantially more stable. This observation was also made with a Burkitt's lymphoma cell line which has a translocated, truncated c-myc gene. Therefore truncation of the c-myc gene can cause the mRNA to be more stable than the full size product suggesting that this can be a crucial factor in the activation of the c-myc oncogene, by exon 1 loss, in chromosomal translocation. The results also suggest a role for exon 1 in the c-myc mRNA degradative mechanism.

PubMed Disclaimer

Similar articles

• Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
  Rabbitts TH, Forster A, Hamlyn P, Baer R. Rabbitts TH, et al. Nature. 1984 Jun 14-20;309(5969):592-7. doi: 10.1038/309592a0. Nature. 1984. PMID: 6547209
• Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.
  Croce CM, Erikson J, ar-Rushdi A, Aden D, Nishikura K. Croce CM, et al. Proc Natl Acad Sci U S A. 1984 May;81(10):3170-4. doi: 10.1073/pnas.81.10.3170. Proc Natl Acad Sci U S A. 1984. PMID: 6328505 Free PMC article.
• Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives.
  Eick D, Piechaczyk M, Henglein B, Blanchard JM, Traub B, Kofler E, Wiest S, Lenoir GM, Bornkamm GW. Eick D, et al. EMBO J. 1985 Dec 30;4(13B):3717-25. doi: 10.1002/j.1460-2075.1985.tb04140.x. EMBO J. 1985. PMID: 3004968 Free PMC article.
• Conditioned tumorigenicity of activated oncogenes.
  Klein G, Klein E. Klein G, et al. Cancer Res. 1986 Jul;46(7):3211-24. Cancer Res. 1986. PMID: 3011242 Review.
• The effect of translocations on the cellular myc gene in Burkitt lymphomas.
  Mitchell KF, Battey J, Hollis GF, Moulding C, Taub R, Leder P. Mitchell KF, et al. J Cell Physiol Suppl. 1984;3:171-7. doi: 10.1002/jcp.1041210420. J Cell Physiol Suppl. 1984. PMID: 6378935 Review.

Cited by

• Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription.
  Schwab M, Klempnauer KH, Alitalo K, Varmus H, Bishop M. Schwab M, et al. Mol Cell Biol. 1986 Jul;6(7):2752-5. doi: 10.1128/mcb.6.7.2752-2755.1986. Mol Cell Biol. 1986. PMID: 3785211 Free PMC article.
• Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.
  Schuetze S, Paul R, Gliniak BC, Kabat D. Schuetze S, et al. Mol Cell Biol. 1992 Jul;12(7):2967-75. doi: 10.1128/mcb.12.7.2967-2975.1992. Mol Cell Biol. 1992. PMID: 1620109 Free PMC article.
• Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component.
  Brewer G, Ross J. Brewer G, et al. Mol Cell Biol. 1989 May;9(5):1996-2006. doi: 10.1128/mcb.9.5.1996-2006.1989. Mol Cell Biol. 1989. PMID: 2747642 Free PMC article.
• A human chromosome 8 region with abnormalities in B cell, HTLV-I+ T cell and c-myc amplified tumours.
  Mengle-Gaw L, Rabbitts TH. Mengle-Gaw L, et al. EMBO J. 1987 Jul;6(7):1959-65. doi: 10.1002/j.1460-2075.1987.tb02458.x. EMBO J. 1987. PMID: 2820714 Free PMC article.
• High frequency of large spontaneous deletions of DNA in tumor-derived CHEF cells.
  Kaden DA, Bardwell L, Newmark P, Anisowicz A, Skopek TR, Sager R. Kaden DA, et al. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2306-10. doi: 10.1073/pnas.86.7.2306. Proc Natl Acad Sci U S A. 1989. PMID: 2928335 Free PMC article.

References

1. 1. Nature. 1983 Jul 14-20;304(5922):135-9 - PubMed
2. 1. Science. 1983 Nov 18;222(4625):765-71 - PubMed
3. 1. EMBO J. 1983;2(5):697-703 - PubMed
4. 1. Nature. 1983 Nov 10-16;306(5939):194-6 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6922-6 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database